Interestingly, we found that one enriched gene set, MULTIPLE-DRUG-RESISTANCE, was positively correlated with IMPDH2 expression (Fig. 3H), indicating that IMPDH2 may be involved in multiple drug resistance in CRC. The gene discussed is IMPDH2; the disease is colorectal carcinoma.